XenTech has several research collaborations with pharmaceutical and biotechnology companies and with academic institutions.

XenTech has established key collaborations with clinical centers in France, including Institut Curie, to develop xenograft models from patient’s tumor samples in compliance with ethical rules.

Beside offering fee-for service contracts, we are also open to co-development theranostic research projects through joint venture collaborations.